Research & Development
US CDC, FDA Recommend Halt on Use of Johnson and Johnson COVID-19 Vaccine
14 April 2021 - - On April 13 the The United States Centers for Disease Control (CDC) and the US Food and Drug Administration (FDA) issued joint statements regarding the safety of US-based healthcare ...
US Supermarket Operator Publix Suspends Administration of Johnson and Johnson COVID-19 Vaccine Following Guidance
14 April 2021 - - US-based supermarket chain Publix is suspending the administration of the Johnson and Johnson (NYSE: JNJ) COVID-19 vaccine at all of its pharmacy locations following guidance from th...
Infinity BiologiX Awarded CDC Contract to Sequence Variants of COVID-19 Virus and Assist in Global Public Health Response
14 April 2021 - - US-based central laboratory Infinity BiologiX has been awarded a contract from the Centers for Disease Control and Prevention "Genomic Surveillance for SARS-CoV-2 Variants,"...
Elicity to Offer the First COVID-19 Antibody Test to Receive an EUA for Patients to Collect Dried Blood Spot Samples at Home
14 April 2021 - - US-based telehealth platform elicity, powered by InTeleLabs Inc., is now offering the first COVID-19 Antibody test to receive an Emergency Use Authorization that allows patients to c...
Denmark deselects AstraZeneca COVID-19 vaccine from advanced vaccination rollout
14 April 2021 - Denmark has announced that it doesn't need the AstraZeneca COVID-19 vaccine and has removed it from its vaccination programme, CNN news website reported on Wednesday.The Danish He...
elicity to launch first FDA EUA approved COVID-19 antibody test for collection of dried blood spot samples at home
14 April 2021 - Telehealth and personalised medicine company InTelelabs Inc said on Tuesday that its elicity proprietary telehealth plaform is now offering the first COVID-19 antibody test that allows...
Related Headlines

Otsuka and Lundbeck announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia

EU Commission decides not to renew AstraZeneca and J&J COVID-19 vaccine contracts next year

Infinity BiologiX wins CDC contract to sequence variants of COVID-19 Virus in response to global public health

Publix suspends administration of Johnson & Johnson COVID-19 vaccine based on CDC and FDA guidance

Publix suspends administration of Johnson & Johnson COVID-19 vaccine based on CDC and FDA guidance

GenScript Biotech BV partners with IES for distribution of SARS-CoV-2 Neutralizing Antibody Kit in Spain, Portugal and Andorra

US FDA Accepts Filing for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer

SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint

Frankel Named to Precision BioSciences B oard of Directors

Sobi launches phase 3 trial of efanesoctocog alfa in children with haemophilia A

Mirum Pharmaceuticals, Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement

Novartis' Xolair prefilled syringe supplemental Biologics License Application receives US FDA approval

US Centers for Disease Control and Prevention and US Food and Drug Administration advise US pause of Johnson & Johnson COVID-19 vaccine due to concerns about blood clots

ZOLL Medical Corporation expands critical-care portfolio via acquisition of Respicardia Inc

Phase 3 trial of diabetes drug Farxiga showed it did not help hospitalised COVID-19 patients